Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol

GPER Mediates Estrogen-Induced Signaling and Proliferation in Human Breast Epithelial Cells and Normal and Malignant Breast

(2014) Allison L. Scaling et al.   Hormones & Cancer

Biology of the estrogen receptor, GPR30, in triple negative breast cancer

(2013) Jennifer Steiman et al.   AMERICAN JOURNAL OF SURGERY

Targeted Approaches to Triple-Negative Breast Cancer: Current Practice and Future Directions

(2013) A. Brunello et al.   CURRENT MEDICINAL CHEMISTRY

Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy

(2012) Rainer Girgert et al.   BREAST CANCER RESEARCH AND TREATMENT

Synthesis and Characterization of Tricarbonyl-Re/Tc(I) Chelate Probes Targeting the G Protein-Coupled Estrogen Receptor GPER/GPR30

(2012) Ritwik Burai et al.   PLoS One

Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity

(2011) Megan K. Dennis et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Poly(ADP-Ribose) Polymerase Inhibition: "Targeted" Therapy for Triple-Negative Breast Cancer

(2010) C. K. Anders et al.   CLINICAL CANCER RESEARCH

Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells

(2010) Rosamaria Lappano et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

A Proposed Unified Mechanism for the Reduction of Human Breast Cancer Risk by the Hormones of Pregnancy

(2009) H. I. Jacobson et al.   Cancer Prevention Research

Stimulating the GPR30 Estrogen Receptor with a Novel Tamoxifen Analogue Activates SF-1 and Promotes Endometrial Cell Proliferation

(2009) Benjamin C. Lin et al.   CANCER RESEARCH

GPR30 predicts poor survival for ovarian cancer

(2009) Harriet O. Smith et al.   GYNECOLOGIC ONCOLOGY

Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen

(2009) Mitch Dowsett et al.   JOURNAL OF CLINICAL ONCOLOGY

Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells

(2009) Rainer Girgert et al.   JOURNAL OF PINEAL RESEARCH